According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.
Hepatic Perfusion: High-Dose Chemotherapy, Few Ill Effects
Hepatic Perfusion: High-Dose Chemotherapy, Few Ill Effects
Avoiding Unnecessary Delays in Diagnosing Bladder Cancer
Avoiding Unnecessary Delays in Diagnosing Bladder Cancer
Retinoblastoma Therapy to Save Vision, Rebuilding Lives
Retinoblastoma Therapy to Save Vision, Rebuilding Lives
New Technology Platforms to Detect Lymphedema
New Technology Platforms to Detect Lymphedema
Lymphedema: The Untold Story After Mastectomy
Lymphedema: The Untold Story After Mastectomy
The Emerging Field of Clinical Cancer Genomics
The Emerging Field of Clinical Cancer Genomics
Inherited Susceptibility to Common Cancers
Inherited Susceptibility to Common Cancers
A Way to Boost Cancer Cell Vulnerability to Chemotherapy
A Way to Boost Cancer Cell Vulnerability to Chemotherapy
Potential Future Treatments for Human Papilloma Virus (HPV)
Potential Future Treatments for Human Papilloma Virus (HPV)
Does Your Patient’s Anxiety Point to Pancreatic Cancer?
Does Your Patient’s Anxiety Point to Pancreatic Cancer?
Thriving Egg Business: Problems & Solutions
Thriving Egg Business: Problems & Solutions
Oncofertility and Family Planning for Cancer Survivors
Oncofertility and Family Planning for Cancer Survivors
Developing New Therapies to Treat Glioblastoma
Developing New Therapies to Treat Glioblastoma
A Blood Test for Lung Cancer?
A Blood Test for Lung Cancer?
Strategies to Overcome Cancer Drug Resistance
Strategies to Overcome Cancer Drug Resistance